# Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients

> **NCT01866904** · — · TERMINATED · sponsor: **AstraZeneca** · enrollment: 9284 (actual)

## Conditions studied

- Stable Coronary Artery Disease (CAD), Myocardial Infarction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01866904
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-06-19
- **Primary completion:** 2017-03-31
- **Final completion:** 2017-03-31
- **Target enrollment:** 9284 (ACTUAL)
- **Why stopped:** Study was terminated in order to secure the data quality of the study in terms of follow-up rates and data completeness.
- **Last updated:** 2018-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01866904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01866904, "Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01866904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*